Schedule 13G ownership disclosure

ARIDIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 040334104

Event date: 2021-07-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
884,956
Percent of class
7.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-096237
Form type
SC 13G
Filer
ASTRAZENECA PLC
CIK
CIK 901832
Filed
Jul 27, 2021
Reporting period
Jul 20, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub